Chen-yi Tang
139 Ren Min Middle Road
Changsha, 410011, China
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A novel solid beverage RLMCR prevents obesity-related metabolic disorders through the gut-adipose axis.
Journal: Frontiers in nutrition
Published: May 30, 2026
Targeting the Gpr125-Gper1 axis: a novel osteogenic signaling pathway with therapeutic potential against osteoporosis.
Journal: Journal of translational medicine
Published: December 28, 2025
Correction: Runx1 is a central regulator of osteogenesis for bone homeostasis by orchestrating BMP and WNT signaling pathways.
Journal: PLoS genetics
Published: October 31, 2022
Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis.
Journal: International journal of biological sciences
Published: February 20, 2022
GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways.
Journal: International journal of biological sciences
Published: December 30, 2021
Association of Sex Hormones and Fat Distribution in Men with Different Obese and Metabolic Statuses.
Association of Sex Hormones and Fat Distribution in Men with Different Obese and Metabolic Statuses.
Journal: International journal of general medicine
Published: December 02, 2021
Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: A two-center cohort study.
Journal: Journal of medical virology
Published: November 01, 2021
Changes in Bone Mineral Density Following Conventional Oral Phosphonate Treatment of Hypophosphatemic Osteomalacia: A Non-Randomized Controlled Study.
Journal: International journal of general medicine
Published: August 03, 2021
Long Non-coding RNA 332443 Inhibits Preadipocyte Differentiation by Targeting Runx1 and p38-MAPK and ERK1/2-MAPK Signaling Pathways.
Journal: Frontiers in cell and developmental biology
Published: February 04, 2021
Serum miR-503 is a Candidate Biomarker for Differentiating Metabolic Healthy Obesity from Metabolic Unhealthy Obesity.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 19, 2020
Last Updated: 09/26/2026